IBXIMAGION BIOSYSTEMS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Aug 2026, 20:21 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Aug 2026, 20:18 | Application for quotation of securities - IBX | Other | — | 06020 | |
| 18 Aug 2026, 19:30 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Aug 2026, 19:29 | Application for quotation of securities - IBX | Other | — | 06020 | |
| 10 Aug 2026, 22:42 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 31 July 2026, 19:13 | Appendix 4C and Quarterly Activities Report - June 2026 | Quarterly Reports | MS | 19002, 19007 | |
| 29 July 2026, 01:59 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 29 July 2026, 01:58 | Non-Dilutive Short-Term Funding Secured | Securities Administration | — | 06009 | |
| 8 July 2026, 19:32 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 | |
| 7 July 2026, 19:39 | Imagion Extends Collaboration with Siemens Healthineers | Company Update | — | 11001 | |
| 2 July 2026, 19:33 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 July 2026, 19:26 | Application for quotation of securities - IBX | Other | — | 06020 | |
| 1 July 2026, 21:22 | Change of Director's Interest Notices - RP, BM, NW | Director Interests | — | 02009 | |
| 26 June 2026, 00:47 | Notification regarding unquoted securities - IBX | Other | — | 06021 | |
| 26 June 2026, 00:18 | Update - Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 19:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 19:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 19:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 19:28 | IBX Secures Firm Commitments for $3.75m for Clinical Trial | Capital Raising | MS | 06003, 09014 | |
| 23 June 2026, 19:33 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 13 June 2026, 01:31 | Notification of cessation of securities - IBX | Other | — | 06027 | |
| 2 June 2026, 19:05 | Imagion Biosystems Receives IND Clearance from US FDA | Company Update | MS | 11001 | |
| 29 May 2026, 01:00 | Notification of cessation of securities - IBX | Other | — | 06027 | |
| 27 May 2026, 01:21 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 26 May 2026, 19:45 | Investor Presentation | Presentations | — | 03026 | |
| 26 May 2026, 19:42 | IBX Chairman's AGM Address | Letters & Addresses | — | 15002 | |
| 8 May 2026, 22:06 | Change of Director's Interest Notice - Robert Proulx | Director Interests | — | 02009 | |
| 4 May 2026, 22:11 | Notification of cessation of securities - IBX | Other | — | 06027 | |
| 24 Apr 2026, 21:16 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 24 Apr 2026, 00:39 | Notification regarding unquoted securities - IBX | Other | — | 06021 | |
| 24 Apr 2026, 00:14 | Cleansing Statement - Section 708A(12C)(e) | Securities Administration | — | 06018 | |
| 23 Apr 2026, 22:16 | Appendix 4C and Quarterly Activities Report - March 2026 | Quarterly Reports | MS | 19001, 19006 | |
| 17 Apr 2026, 02:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 8 Apr 2026, 20:50 | IBX Update Regarding Short Term Funding Facilities | Securities Administration | — | 06009 | |
| 8 Apr 2026, 01:08 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 3 Apr 2026, 03:09 | Notification of cessation of securities - IBX | Other | — | 06027 | |
| 3 Apr 2026, 02:16 | Appendix 3H Lodged Late - Part Repayment of Convertible Note | Company Administration | — | 06009, 12008 | |
| 3 Apr 2026, 02:14 | Notification of cessation of securities - IBX | Other | — | 06027 | |
| 28 Feb 2026, 01:57 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Feb 2026, 01:55 | FY25 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 2 Feb 2026, 20:17 | IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial | Company Update | MS | 11001 | |
| 29 Jan 2026, 20:50 | Appendix 4C and Quarterly Activities Report - December 2025 | Quarterly Reports | MS | 19004, 19009 | |
| 9 Jan 2026, 20:41 | Cleansing Notice | Securities Administration | — | 06018 | |
| 9 Jan 2026, 20:33 | Application for quotation of securities - IBX | Other | — | 06020 | |
| 8 Jan 2026, 21:07 | Mercer Convertible Securities Conversion and Amendment | Securities Administration | MS | 06009 | |
| 7 Jan 2026, 02:13 | Change of Director's Interest Notice - Robert Proulx | Director Interests | — | 02009 | |
| 7 Jan 2026, 02:10 | Cleansing Notice | Securities Administration | — | 06018 | |
| 7 Jan 2026, 02:06 | Application for quotation of securities - IBX | Other | — | 06020 | |
| 19 Dec 2025, 01:03 | Updated Securities Trading Policy | Company Administration | — | 14013 | |
| 15 Dec 2025, 20:53 | Cleansing Notice | Securities Administration | — | 06018 |
1–50 of 81
1 / 2